As the leader of the Synthesis group for Oncology Medicinal Chemistry, the successful applicant will lead a group of 35+ primarily lab-based colleagues to deliver first-in-class breakthrough cancer therapies that change patients lives. The Synthesis group head will partner with other scientific leaders to ensure that Oncology drug discovery programs have the optimal synthetic and medicinal chemistry strategy in place to rapidly deliver high quality clinical candidates to the clinic.
ROLE RESPONSIBILITIES
* Lead the Oncology Synthesis team, fostering a patient-centric culture focused on delivering the next generation of Oncology therapies with urgency and scientific excellence. Foster strong teamwork, innovation, thoughtful risk-taking, diversity, and a culture of inclusion.
* Take shared accountability for creating and maintaining a sustainable small molecule Oncology portfolio with an emphasis on first in class therapies, helping to define the drug discovery strategy in partnership with the Oncology Med Chem LT, as well as leaders in the Oncology Research Unit and other relevant disciplines.
* Work closely with the Oncology Design group to build strategic alignment and a robust synthesis/design collaborative culture.
* Manage a significant outsourcing budget utilizing CRO FTEs and fee-for-service work to maximize its impact on portfolio delivery.
* Accountable for the delivery of robust and scalable routes that can transition rapidly to Pharmaceutical Sciences for further development.
* In partnership with other leaders, develop a workforce plan to ensure appropriate long term balances of skill sets on the Synthesis team.
* Foster the career development and retention of the next generation of leaders in Med Chem.
* Serve on the Oncology Medicinal Chemistry leadership team, helping to set the groups strategy, vision, deliverables, and culture.
* Collaborate closely with other scientific leaders across Med Chem, Pharmaceutical Sciences, and Applied Synthesis Technology.
* Play a leading role in enhancing the external reputation of Pfizers medicinal chemistry and synthetic capabilities through high profile publications and presentations at leading conferences.
BASIC QUALIFICATIONS
Candidate demonstrates a breadth of diverse leadership experiences and capabilities including: the ability to influence and collaborate with peers, develop and coach others, oversee and guide the work of other colleagues to achieve meaningful outcomes and create business impact.
* Doctorate level degree in relevant area of science, or equivalent industrial experience
* Minimum 8-10 years of relevant experience in the pharmaceutical industry
* Strong track record of delivering high impact contributions to Med Chem projects, including to projects that have delivered agents into the clinic
* Track record of supervisory experience and expertise in developing talent
* Working knowledge of the key research and development disciplines and scientific lines responsible for pharmaceutical drug discovery and development
* Experience in leading matrixed teams of internal/CRO staff scientist to deliver project objectives
* Consistent record of peer-reviewed publications from scientific work to date, to include medicinal chemistry/ drug discovery
PREFERRED QUALIFICATIONS
* Track record of developing key leaders in medicinal chemistry
* Working knowledge of small molecule design including structure-based design, property and ligand-based design, pharmacokinetics, and hit ID strategies.
Addition Job Information
* Last day to apply: March 9, 2021
* Eligible for employee referral program
* Relocation support available
Sunshine Act
Pfizer reports payments and other transfers of value to health care providers as required by federal and state transparency laws and implementing regulations. These laws and regulations require Pfizer to provide government agencies with information such as a health care providers name, address and the type of payments or other value received, generally for public disclosure. Subject to further legal review and statutory or regulatory clarification, which Pfizer intends to pursue, reimbursement of recruiting expenses for licensed physicians may constitute a reportable transfer of value under the federal transparency law commonly known as the Sunshine Act. Therefore, if you are a licensed physician who incurs recruiting expenses as a result of interviewing with Pfizer that we pay or reimburse, your name, address and the amount of payments made currently will be reported to the government. If you have questions regarding this matter, please do not hesitate to contact your Talent Acquisition representative.
EEO & Employment Eligibility
Pfizer is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Pfizer also complies with all applicable national, state and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Pfizer is an E-Verify employer.
Research and Development
LI-PFE
New York, New York
Pfizer Inc. develops, manufactures, and sells healthcare products worldwide. It offers medicines and vaccines in various therapeutic areas, including internal medicine, vaccines, oncology, inflammation and immunology, and rare diseases under the Lyrica, Chantix/Champix, Eliquis, Ibrance, Sutent, Xalkori, Inlyta, Xtandi, Enbrel, Xeljanz, Eucrisa, BeneFix, Genotropin, and Refacto AF/Xyntha brands. The company also provides consumer healthcare products that comprise over-the-counter medicines, including dietary supplement products under the Centrum, Caltrate, and Emergen-C names; pain management products under the Advil and ThermaCare names; gastrointestinal products under the Nexium 24HR/Nexium Control and Preparation H names; and respiratory and personal care products under the Robitussin, Advil Cold & Sinus, and ChapStick names. In addition, it offers products that would lose or have lost marketing patent protection; branded generic products; generic sterile injectable products; biosimilars; and anti-infectives under the Lipitor, Premarin family, Norvasc, Lyrica, Celebrex, Viagra, Inflectra/Remsima, Zyvox, Vfend, Revatio, Inspra, Medrol, Sulperazon, Fragmin, Tygacil, Nivestim, and Retacrit, Ixifi Infliximab BS names.
Further, the company is also involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration and/or co-promotion agreements with Bristol-Myers Squibb Company, Astellas Pharma US, Inc., and Oncolytics Biotech Inc.; licensing agreement with BionTech AG; strategic alliance with Verily Life Sciences LLC; and collaboration agreements with Pfizer, Merck & Co., Inc., and Eli Lilly & Company, as well as with Merck KGaA and Nektar Therapeutics to develop a therapy for treating pancreatic cancer. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.